Anteris Technologies Global Corp. Common Stock (AVR) is a publicly traded Healthcare sector company. As of November 1, 2026, AVR trades at $6.32 with a market cap of $614.96M and a P/E ratio of -3.57. AVR moved -1.64% today. Year to date, AVR is +28.25%; over the trailing twelve months it is +46.40%. Its 52-week range spans $2.34 to $11.06. Analyst consensus is buy with an average price target of $13.67. Rallies surfaces AVR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks AVR insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $6.32 |
| Market Cap | $614.96M |
| P/E Ratio | -3.57 |
| EPS | $-1.95 |
| Dividend Yield | 0.00% |
| 52-Week High | $11.06 |
| 52-Week Low | $2.34 |
| Volume | 1.22M |
| Avg Volume | 0 |
| Revenue (TTM) | $2.24M |
| Net Income | $-102.91M |
| Gross Margin | 74.98% |
3 analysts cover AVR: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $13.67.